poisar

Stocks · News reference

Evolv Technologies Q2 Adj. EPS $(0.02), Inline, Sales $43.753M Beat $41.809M Estimate

Benzinga Newsdesk

Evolv Technologies (NASDAQ:EVLV) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

EVLV
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Glancy Prongay Wolke & Rotter Llp

    Glancy Prongay Wolke & Rotter LLP Obtains Final Approval of $15 Million Settlement in Evolv Technologies Securities Class Action

    A federal court in Massachusetts granted final approval of a $15 million settlement resolving securities fraud claims against Evolv Technologies Holdings, Inc. The settlement covers investors who purchased Evolv stock between June 28, 2021 and October 25, 2024. The litigation alleged false statements regarding the effectiveness of Evolv Express, improper customer arrangements, and financial misstatements that led to a restatement of fiscal years 2022 and 2023 financial statements.

    EVLV